CIRI Oncology Research Alliance (CORA)

CIRI肿瘤学研究联盟（CORA）

• 批准号: 8902081
• 负责人: Dax Kurbegov
• 金额: $ 78万
• 依托单位: COMMONSPIRIT HEALTH RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8902081
• 关键词: Access to Information; Address; Adoption; Budgets; Cancer Center; Caring; Clinical Research; Clinical Trials; Communities; Community Clinical Oncology Program; Community Networks; Community Outreach; Country; Data; Databases; Detection; Education; Electronic Health Record; Enrollment; Ethnic Origin; Evaluation; Feeds; Glean; Goals; Growth; Guidelines; Health; Home environment; Human; Informed Consent; Institutes; Institutional Review Boards; Leadership; Learning; Legal; Link; Malignant Neoplasms; Marketing; Measurable; Minority Groups; Modeling; National Cancer Institute; Nurses; Office Management; Oncologist; Patients; Patterns of Care; Physicians; Population; Population Heterogeneity; Positioning Attribute; Process; Race; Research; Research Infrastructure; Research Institute; Research Support; Resources; Rural; Services; Site; Specimen; Structure; System; Target Populations; Testing; The Cancer Genome Atlas; Training; Translating; Translational Research; Underrepresented Minority; Underserved Population; anticancer research; base; cancer care; cancer prevention; care delivery; community setting; design; experience; health care delivery; improved; innovation; meetings; multidisciplinary; oncology; oncology service; personalized medicine; programs; prospective; quality assurance; research study; response; sample collection; screening; survivorship; symposium; tumor registry

DESCRIPTION (provided by applicant): The CHI Institute for Research and Innovation's Oncology Research Alliance (CIRI-CORA) uses a unique and innovative research model that optimizes the National Cancer Institute's community oncology research platform and incorporates best practices CHI's National Oncology Service Line instituted through the NCCCP. CORA capitalizes on the existing structure of our Institute for Research and Innovation (CIRI) and their system-wide clinical trials management system; standardized processes including a centralized IRB, informed consent management, and legal approvals; collaborative leadership and governance entity; unique network of community cancer centers with diverse populations, variable practices and geographic reach; staff education; aligned oncologists; best practices from the NCCCP, and a rigorous, prospective quality assurance program to provide the infrastructure needed to excel in community cancer research. Goals for CORA include: 1.) Increasing enrollment in cancer clinical trials by providing access to a wide portfolio of high quality research studies that meet the needs of our diverse and disparate populations. We will annually accrue 10% of our new cancer cases within target populations to research trials, 2.) Identifying, designing and implementing cancer care delivery research that leads to improved models of care and translates to high quality, value based services throughout the oncology continuum, and 3.) Expanding our efforts to explore and address the cancer care needs of racial and ethnic minorities as well as other defined disparate populations. CORA includes seven of CHI's market-based (care delivery) organizations across six states. CHI leadership developed CIRI in 2007 in response to the ever-increasing complexity of human cancer research and the lack of resources, expertise, or access that often characterize community based cancer programs. CIRI supports the conduct of standardized high quality clinical research in the community setting, exploring innovative models of health care delivery, and accelerating the adoption of personalized medicine through bio-specimen collection and evaluation.

描述（由申请人提供）：CHI研究与创新研究所的肿瘤学研究联盟（CIRI-CORA）采用了独特而创新的研究模型，可优化国家癌症研究所的社区肿瘤学研究平台，并结合了Chi Chi的国家肿瘤学服务系列，该计划通过NCCCP建立了。 Cora利用了我们研究与创新研究所（CIRI）及其全系统临床试验管理系统的现有结构；标准化流程，包括集中的IRB，知情同意管理和法律批准；协作领导和治理实体；社区癌症中心的独特网络，具有不同的人群，可变实践和地理范围； 员工教育；一致的肿瘤学家； NCCCP的最佳实践以及一项严格，预期的质量保证计划，以提供在社区癌症研究中表现出色所需的基础设施。 Cora的目标包括：1。）增加癌症临床试验的入学率，通过提供了满足我们多样化和不同人群需求的广泛高质量研究组合的访问。我们每年将在目标人群中每年累积10％的新癌症病例，以进行研究试验，2。）确定，设计和实施癌症护理提供研究，从而改善了护理模型，并转化为在整个肿瘤学连续性过程中，以及3.）扩大我们的努力，以扩大我们的努力，以探索和解决种族和少数族裔的癌症护理需求，以及其他少数群体以及其他分散的人群。 Cora包括六个州的Chi七个基于市场的（护理交付）组织。 Chi Leaderion在2007年开发了CIRI，以响应人类癌症研究的不断增长以及缺乏资源，专业知识或访问权限，而这些资源，专业知识或访问通常通常是基于社区的癌症计划的特征。 CIRI支持社区环境中标准化高质量临床研究的行为，探索卫生保健提供的创新模型，并通过生物特异性收集和评估加速采用个性化医学。